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We examined the inﬂuence of chronic adrenocorticotropic hormone (ACTH) treatment on the number 
of Ki-67-positive cells in the dentate gyrus of the hippocampus in rats.  ACTH treatment for 14 days 
decreased the number of such cells.  The administration of imipramine or lithium alone for 14 days had 
no eﬀect in saline-treated rats.  The eﬀect of ACTH was blocked by the administration of imipramine.  
Furthermore,  the coadministration of imipramine and lithium for 14 days signiﬁcantly increased the 
number of Ki-67-positive cells in both the saline and ACTH-treated rats.  The coadministration of imi-
pramine and lithium normalized the cell proliferation in the dentate gyrus of the hippocampus in rats 
treated with ACTH.
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sychoendocrinological studies have focused on 
the regulation of the hypothalamic-pituitary-
adrenal (HPA) axis in patients with depression [1].  
Cortisol hypersecretion in depression is believed to 
result from abnormalities in the HPA axis [1,  2].  
Multiple neuroendocrinological abnormalities appear 
in subjects with depressive disorders,  including 
increases in cortisol secretion and the attenuation of 
cortisol suppression in response to dexamethasone 
[3].  Cortisol hypersecretion in depression is believed 
to result from abnormalities in the HPA axis.  
Patients with Cushingʼs disease,  a hyperadrenocorti-
cism following a pituitary tumor,  an adrenal tumor,  or 
a tumor producing ectopic adrenocorticotropic hor-
mone (ACTH),  often exhibit mental changes including 
depression [4,  5].  Tricyclic antidepressants are not 
eﬀective for the treatment of depression in patients 
with Cushingʼs disease,  but steroid-suppressive agents 
such as metyrapone and aminogluethimide are eﬀective 
for depression in such cases [6],  suggesting an etio-
logical link between depressive illness and the disinhi-
bition of the HPA axis observed in subjects with 
Cushingʼs disease.  In addition,  steroid-suppressive 
agents,  such as metyrapone and ketoconazole,  and a 
glucocorticoid receptor antagonist,  RU486,  are eﬀec-
tive treatments for antidepressant treatment-resistant 
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depression [5,  7,  8].  These results suggest that 
abnormal activation of the HPA axis correlates with 
treatment-resistant depression.  We previously reported 
that the chronic administration of ACTH to rats 
counteracted the decrease in immobility time induced 
by a tricyclic antidepressant,  imipramine or desipra-
mine,  in the forced swim test,  which is widely used as 
a predictor of antidepressant activity [9].  Further-
more,  chronic coadministration of lithium,  an agent 
that potentiates the actions of antidepressants in 
patients with depression,  including those with treat-
ment-resistant depression [10],  signiﬁcantly decreased 
the duration of immobility,  even when given concur-
rently with ACTH [9].  Chronic treatment of rats with 
ACTH may therefore be an eﬀective model of tricyclic 
antidepressant treatment-resistant conditions.
　 Chronic treatment with antidepressants may 
increase cell proliferation and granule cell survival 
and reverse stress-induced decreases in hippocampal 
cell proliferation and neurogenesis [11,  12].  The 
ability to promote hippocampal neurogenesis is a fea-
ture of both classical antidepressants,  such as selec-
tive serotonin re-uptake inhibitors,  and tricyclic 
drugs [13-15].  Moreover,  hippocampal cell prolif-
eration and neurogenesis might be key factors in the 
actions of antidepressant drugs.
　 The nuclear protein Ki-67 is an endogenous marker 
of cell proliferation,  being expressed in all phases of 
the cell cycle except the resting phase [16,  17].  We 
hypothesized that chronic ACTH treatment would lead 
to a decrease in cell proliferation within the dentate 
gyrus that could be reversed by the coadministration 
of imipramine and lithium in rats.  This study exam-
ined the immunolocalization of Ki-67 in the rat dentate 
gyrus to evaluate the eﬀect of imipramine and lithium 
on adult hippocampal cell proliferation.
Materials and Methods
　 Animals. Male Wistar rats (Charles River,  
Yokohama,  Japan) with an initial weight of 220-230g 
were utilized.  The rats were group-housed,  4 per 
cage,  under a constant light-dark cycle (lights on,  
07:00-19:00 hours) and fed standard laboratory food 
and tap water in an air-conditioned room (23±1℃ 
with approximately 60ｵ humidity).  All experiments 
were conducted according to the guidelines for animal 
experimentation at Okayama University Medical 
School.  Every eﬀort was made to minimize the num-
ber and suﬀering of the animals used.  Four to 6 ani-
mals were used for each group.
　 Drugs. The following drugs were used:  
imipramine hydrochloride (Sigma),  lithium carbonate 
(Taisho Pharmaceutical,  Tokyo,  Japan) and ACTH-(1-
24)-zinc (Cortrosyn-Z: Daiichi-Sankyo,  Tokyo,  Japan).  
Imipramine was dissolved in saline.  Lithium was sus-
pended in a 0.5ｵ methylcellulose solution.  The rats 
were administered imipramine and lithium at a dosage 
of 2ml/kg of body weight for 14 days.  ACTH 
(Cortrosyn-Z) was injected subcutaneously once daily 
(09:00 to 10:00 hours) at 100µg/rat (the injection 
volume was 0.2ml/rat) for 14 days.  The control rats 
received an equivalent volume of vehicle (saline 
0.2ml/rat) subcutaneously for the same period of 
time.
　 Immunohistochemistry. One day after the 
last drug administration,  rats were transcardially 
perfused with ice-cold saline followed by a ﬁxative 
containing 4ｵ paraformaldehyde and 0.35ｵ glutaral-
dehyde in 0.1M phosphate buﬀer (PB,  pH7.4) under 
deep pentobarbital sodium anesthesia (80mg/kg,  i.p.).  
After the perfusion,  the brain was rapidly removed en 
bloc from the skull,  post-ﬁxed for 24h in a ﬁxative 
containing 4ｵ paraformaldehyde in 0.1M PB (pH7.4),  
and cryoprotected in 15ｵ sucrose in 0.1M PB with 
sodium azide for ～48h.  Brains snap-frozen with 
powdered dry ice were cut coronally on a cryostat 
into 20-µm thick sections containing the dentate gyrus 
of the hippocampus.  The sections were collected in 
10mM phosphate-buﬀered saline (PBS) with 0.1ｵ 
sodium azide for staining.  Standard free-ﬂoating 
immunohistochemistry was used to detect Ki-67-
immunopositive signals in the dentate gyrus of the 
hippocampus.  For this purpose,  an adjacent set of 
equally spaced brain sections containing the hip-
pocampus was selected from all the animals examined.  
The sections were soaked in 10mM PBS containing 
0.2ｵ Triton X-100 (PBST) for 30min at room tem-
perature.  After incubation in 1ｵ normal goat serum 
for Ki-67 in PBST for 30min,  the sections were 
exposed to a rabbit anti-Ki-67 monoclonal antibody 
(diluted 1:500 in PBST; Lab Vision,  Fremont,  CA,  
USA) for 18h at 4℃.  The sections were then washed 
in  PBST (5×5min) and incubated with a goat anti-
rabbit IgG Alexa Fluor 488 antibody (diluted 1:500 in 
PBST; Invitrogen,  Carlsbad,  CA,  USA) for 2h at 
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room temperature.  Following washes in PBS (3×
10min),  the sections were stained with 10µg/ml of 
Hoechst33258 for 30 sec to visualize cell nuclei.  All 
slides were analyzed under a ﬂuorescence microscope 
(Olympus BX50-FLA; Olympus,  Tokyo,  Japan) using 
a mercury lamp through a 470-490 nm or 360-370 nm 
band-pass ﬁlter to excite the Alexa Fluor 488 or 
Hoechst dye,  respectively.  The light emitted from 
Alexa Fluor 488 or Hoechst was collected through a 
515-550 nm band-pass ﬁlter or 420 nm long-pass ﬁlter,  
respectively.  The stained cells were photographed at 
a magniﬁcation of ×200.  The Ki-67-positive cells of 
the dentate gyrus of the hippocampus were counted 
manually on two slices per animal using a microscope 
by an investigator blinded to the experiments.
　 Statistical analysis. All values are expressed 
as the group mean ± S.E.M.  The group means were 
assessed using Studentʼs t-test,  and compared using 
Tukeyʼs test for multiple comparisons.
Results
　 Eﬀects of chronic ACTH treatment on the 
number of Ki-67-positive cells in the dentate 
gyrus of the hippocampus. Fig.  1 and 2 show 
the number of Ki-67-positive cells in the dentate gyrus 
of the hippocampus.  At 1 day after the ﬁnal adminis-
tration of ACTH (100µg/rat,  s.c.,  14 days),  the 
number was signiﬁcantly decreased compared with the 
control value (p＜0.01).
　 Eﬀects of chronic treatment with imipramine 
and lithium for 14 days on the number of 
Ki-67-positive cells in the dentate gyrus of the 
hippocampus in saline and ACTH-treated rats.
Neither chronic administration of imipramine (10mg/
kg,  i.p.) nor chronic administration of lithium (100mg/
kg,  p.o.) for 14 days aﬀected the number of Ki-67-
positive cells in the dentate gyrus of the hippocampus.  
However,  the coadministration of imipramine (10mg/
kg,  i.p.) and lithium (100mg/kg,  p.o.) for 14 days 
signiﬁcantly increased the number (F(3,  39)＝7.821,  
p＜0.01) (Fig.  3).  Treatment with ACTH (100µg/
rat,  s.c.) for 14 days signiﬁcantly decreased the num-
ber (Fig.  4).  This eﬀect was not inﬂuenced by the 
chronic administration of lithium,  but was enhanced by 
the administration of imipramine,  or coadministration 
of imipramine and lithium for 14 days (F(4,  43)＝
9.702,  p＜0.01) (Fig.  4).
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Fig. 1　 Eﬀects of chronic ACTH treatment on the number of 
Ki-67-positive cells in the dentate gyrus of the hippocampus.  Rats 
were administered ACTH (100µg/rat,  s.c.) once daily for a period 
of 14 days. The number of Ki-67-positive cells in the dentate gyrus 
of the hippocampus was measured the day after the ﬁnal ACTH 
treatment.  The rats were killed by decapitation and their brains 
were removed 1 day after the ﬁnal administration of ACTH.  Values 
are expressed as the mean±S.E.M.  for 5 animals.  Data were 
analyzed with Studentʼs t-test.  ＊＊p＜0.01,  signiﬁcantly diﬀerent 
from the control value.
Control
ACTH
Fig. 2　 Representative ﬂuorescence photomicrographs of the 
eﬀect of chronic ACTH treatment on the number of Ki-67-positive 
cells in the dentate gyrus of the hippocampus.
Discussion
　 We observed that chronic ACTH treatment 
reduced the number of Ki-67-positive cells in the 
dentate gyrus of the hippocampus.  We previously 
found that plasma corticosterone levels in rats follow-
ing a 14-day chronic ACTH treatment (100µg/day,  
s.c.) were signiﬁcantly higher than those in saline-
treated rats (saline: 1.1±0.2mg/dl; 14 days: 13.9±
3.0mg/dl).  We thereby demonstrated that chronic 
ACTH treatment in rats produced a signiﬁcant eleva-
tion in corticosterone levels compared with nontreated 
controls,  a condition termed hypercorticism.  Given 
the repetitive activation of the HPA axis,  it seems 
probable that glucocorticoids play an important role in 
the development of aberrant brain function after 
chronic ACTH treatment,  e.g.,  in the suppression of 
cell proliferation and neurogenesis.  It has been 
reported that a glucocorticoid receptor antagonist 
normalized the depressive eﬀects of chronic stress on 
adult neurogenesis [18].  In the present study,  
chronic ACTH treatment led to strong activation of 
the HPA axis,  suggesting reductions in adult hip-
pocampal cell proliferation and neurogenesis.
　 Furthermore,  neither imipramine nor lithium alone 
aﬀected the number of Ki-67-positive cells in the 
dentate gyrus in saline-treated rats.  Several studies 
have shown an increase in hippocampal cell prolifera-
tion and neurogenesis in rodents following chronic 
treatment with antidepressants such as ﬂuoxetine (a 
selective serotonin re-uptake inhibitor),  imipramine,  
and desipramine (tricyclic antidepressants).  A 
decrease in cell proliferation and neurogenesis in the 
dentate gyrus of the hippocampus has been demon-
strated in diﬀerent animal models of depression [11,  
12].  It has also been shown that stress-induced 
changes in the levels of hippocampal cell proliferation 
and neurogenesis can be reversed by the chronic 
administration of antidepressants [13-15].  It is diﬃ-
cult to explain why imipramine and lithium did not 
increase the number of Ki-67-positive cells in the 
dentate gyrus in saline-treated rats.  It has been 
reported that chronic,  but not subacute,  treatment 
with antidepressants increases cellular proliferation in 
the hippocampus [13].  Furthermore,  there are 
reports,  in mice,  of strain diﬀerences in neurogene-
sis [19].  Thus,  diﬀerences in the number of injec-
tions,  the animal species (mouse or rat),  the animal 
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Fig. 3　Eﬀects of chronic treatment with imipramine and lithium for 
14 days on the number of Ki-67-positive cells in the dentate gyrus 
of the hippocampus of saline-treated rats.  Rats were administered 
imipramine (IMI: 10mg/kg,  i.p.) and lithium (LI: 100mg/kg,  p.o.) 
once daily for a period of 14 days.  Values are expressed as the 
means±S.E.M.  for 5-6 animals.  Data were analyzed with one-
way ANOVA,  followed by Tukeyʼs test.  ＊＊p＜0.01,  signiﬁcantly 
diﬀerent from the control value.
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Fig. 4　 Eﬀects of chronic treatment with imipramine and lithium 
for 14 days on the number of Ki-67-positive cells in the dentate 
gyrus of the hippocampus of ACTH-treated rats.  Rats were admin-
istered imipramine (IMI: 10mg/kg,  i.p.),  lithium (LI: 100mg/kg,  
p.o.) and ACTH (100µg/rat,  s.c.) once daily for a period of 14 days.  
Values are expressed as the means±S.E.M.  for 4-6 animals.  
Data were analyzed with one-way ANOVA,  followed by Tukeyʼs 
test.  ＊＊p＜0.01,  signiﬁcantly diﬀerent from the control value.  ＃p＜
0.05,  ＃＃p＜0.01,  signiﬁcantly diﬀerent from the ACTH value.
strain,  or the experimental design could be reﬂected 
in the experimental results.
　 The coadministration of imipramine and lithium for 
14 days signiﬁcantly increased the number of Ki-67-
positive cells in ACTH-treated rats.  In the central 
nervous system,  lithium alters the dynamics of neu-
rotransmission within serotonergic pathways.  In bio-
chemical studies,  lithium increased 5-HT synthesis in 
the brain,  5-HT turnover in various brain regions in 
rats [20],  and 5-HT release from nerve endings 
[21].  These ﬁndings suggest that the mechanism of 
cell proliferation involves a facilitation of central 
5-HT neurotransmission by the coadministration of 
lithium and imipramine.  However,  the possibility that 
the noradrenergic system is involved in the eﬀects 
observed in the present study can not be excluded.  
Studies are underway to clarify the serotonergic and 
noradrenergic functions on the coadministration of 
imipramine and lithium in chronic ACTH-treated rats.
　 We previously reported that the decrease in immo-
bility induced by single and chronic administration of 
imipramine was blocked by the chronic administration 
of ACTH for 14 days [9].  Thus ACTH-treated rats 
may serve as an animal model of tricyclic antidepres-
sant treatment-resistant depression.  In the present 
study,  we conﬁrmed by means of Ki-67 labeling that 
chronic ACTH treatment suppresses adult cell prolif-
eration,  suggesting that the depressed hippocampal 
cell proliferation is closely related to the pathophysi-
ology of depression or treatment-resistant depression.  
In addition,  we conﬁrmed that hippocampal cell prolif-
eration is required for lithium to augment the eﬀect of 
imipramine in this rodent model of treatment-resistant 
depression.
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